Primary |
Pain |
32.9% |
Product Used For Unknown Indication |
28.3% |
Back Pain |
5.3% |
Drug Exposure During Pregnancy |
4.9% |
Hypertension |
3.7% |
Insomnia |
3.1% |
Musculoskeletal Pain |
3.1% |
Diabetes Mellitus |
2.4% |
Atrial Fibrillation |
1.8% |
Osteoporosis |
1.8% |
Panic Disorder |
1.8% |
Arthralgia |
1.6% |
Prophylaxis |
1.6% |
Fibromyalgia |
1.3% |
Hyperlipidaemia |
1.3% |
Antiemetic Supportive Care |
1.1% |
Epilepsy |
1.1% |
Blood Pressure |
0.9% |
Post Herpetic Neuralgia |
0.9% |
Prophylaxis Of Nausea And Vomiting |
0.9% |
|
Nausea |
11.8% |
Loss Of Consciousness |
10.0% |
Drug Eruption |
8.2% |
Hyperhidrosis |
5.5% |
Somnolence |
5.5% |
Drug Ineffective |
4.5% |
Drug Interaction |
4.5% |
Fall |
4.5% |
Gastric Ulcer |
4.5% |
Injury |
4.5% |
Vomiting |
4.5% |
Death |
3.6% |
Decreased Appetite |
3.6% |
Dementia |
3.6% |
Diabetes Mellitus |
3.6% |
Gamma-glutamyltransferase Increased |
3.6% |
Malaise |
3.6% |
Pneumonia |
3.6% |
Withdrawal Syndrome |
3.6% |
Anxiety Disorder |
2.7% |
|
Secondary |
Pain |
46.1% |
Product Used For Unknown Indication |
14.0% |
Back Pain |
8.6% |
Analgesic Therapy |
3.4% |
Arthralgia |
2.9% |
Hypertension |
2.9% |
Cervicobrachial Syndrome |
2.3% |
Prophylaxis Of Nausea And Vomiting |
2.3% |
Osteoporosis |
2.0% |
Epilepsy |
1.7% |
Foetal Exposure During Pregnancy |
1.7% |
Gastrooesophageal Reflux Disease |
1.7% |
Migraine |
1.7% |
Rhinitis Allergic |
1.7% |
Post Herpetic Neuralgia |
1.4% |
Blood Pressure |
1.1% |
Gastric Disorder |
1.1% |
Insomnia |
1.1% |
Toothache |
1.1% |
Constipation |
0.9% |
|
Drug Eruption |
8.1% |
Nausea |
8.1% |
Withdrawal Syndrome |
8.1% |
Constipation |
6.8% |
Delirium |
6.8% |
Urge Incontinence |
6.8% |
Decreased Appetite |
5.4% |
Dysuria |
5.4% |
Enterocolitis |
5.4% |
Diabetes Mellitus |
4.1% |
Drug Ineffective |
4.1% |
Drug Withdrawal Syndrome Neonatal |
4.1% |
Haemorrhage Subcutaneous |
4.1% |
Loss Of Consciousness |
4.1% |
Pleural Effusion |
4.1% |
Somnolence |
4.1% |
Abdominal Discomfort |
2.7% |
Abnormal Behaviour |
2.7% |
Blood Potassium Decreased |
2.7% |
Dementia |
2.7% |
|
Concomitant |
Product Used For Unknown Indication |
40.8% |
Rheumatoid Arthritis |
14.6% |
Pain |
8.6% |
Hypertension |
4.9% |
Asthma |
3.2% |
Pain In Extremity |
3.0% |
Pharyngitis |
3.0% |
Crohn's Disease |
2.7% |
Osteoporosis |
2.5% |
Prophylaxis |
2.3% |
Bronchitis |
2.2% |
Compression Fracture |
2.0% |
Herpes Zoster |
1.7% |
Neuropathy Peripheral |
1.7% |
Carcinoid Tumour |
1.5% |
Constipation |
1.5% |
Nausea |
1.2% |
Diabetes Mellitus |
1.0% |
Agitation |
0.8% |
Behcet's Syndrome |
0.8% |
|
Gastric Cancer |
15.7% |
Swollen Tongue |
7.8% |
Deep Vein Thrombosis |
5.9% |
Rhabdomyolysis |
5.9% |
Vomiting |
5.9% |
Abortion Spontaneous |
3.9% |
Cardiac Failure |
3.9% |
Cerebral Infarction |
3.9% |
Chills |
3.9% |
Colon Cancer |
3.9% |
Interstitial Lung Disease |
3.9% |
Loss Of Consciousness |
3.9% |
Malaise |
3.9% |
Neuropathy Peripheral |
3.9% |
Oral Herpes |
3.9% |
Pain |
3.9% |
Pulseless Electrical Activity |
3.9% |
Respiratory Depression |
3.9% |
Restlessness |
3.9% |
Road Traffic Accident |
3.9% |
|